Expansion of the National Health Insurance benefits on chronic hepatitis type B and osteoporosis treatments from the coming 1st

Next month, the health insurance benefit of the tenofovir solo therapy will be applied to chronic hepatitis type B multiple drug resistance patients.

Moreover, osteoporosis treatments will be available with the health insurance benefit within 3 years under no condition of bone mineral density as long as osteoporotic fracture is confirmed.

The Ministry of Health and Welfare revised the ‘detail...